ИМПЛАНТАЦИЯ БЕЗЭЛЕКТРОДНОГО ЭЛЕКТРОКАРДИОСТИМУЛЯТОРА ПОСЛЕ УДАЛЕНИЯ ИНФИЦИР ОВАННЫХ ЭЛЕКТРОДОВ

Приводятся результаты обследования и лечения пациентки с полной атриовентрикулярной блокадой, которой после повторных нагноений ложа электрокардиостимулятора, осложненных септическим эндокардитом, произведена имплантация безэлектродного электрокардиостимулятора Micra.

полная атриовентрикулярная блокада, электрокардиостимуляция, гнойные осложнения, септический эндокардит, удаление электродов, безэлектродный электрокардиостимулятор

1. Omdahl P., et al. Right Ventricular Anatomy Can Accommodate Multiple Micra Transcatheter Pacemakers // PACE. 2016; 00: 1-5.

2. Reynolds D, Duray GZ, Omar R et al. A leadless intracardiac transcatheter pacing system. N Eng J Med 2015.

3. Bongiorni MG, Proclemer A, Dobreanu D et al. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey // Europace2013;15: 1664-8.

4. Bonner M, Eggen M, Haddad T et al. Early performance and safety of the micra transcatheter pacemaker in pigs // Pacing Clin Electrophysiol 2015; 38:1248-1259.

5. Udo E.O., et al. Incidence and predictors of short- and long term complications in pacemaker therapy: The FOLLOWPACE stady // Heart Rhythm. 2012; 9:728-735.

6. Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable car-dioverter-defibrillators in the United States 1993 to 2008 // J Am Coll Cardiol. 2011;58((10)):1001-1006.

7. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009;2((2)):129-134.

8. Le KY, Sohail MR, Friedman PA, et al. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis // Pacing Clin Electrophysiol. 2011;34 (4):450-459.

9. Sohail MR, Uslan DZ, Khan AH et al. Risk factor analysis of permanent pacemaker infection // Clin Infect Dis. 2007;45(2):166-173.

10. Sohail MR, Henrikson CA, Braid-Foibes MJ, et al. Mortality and cost associated with cardiovascular implantable electronic device infections // Arch Intern Med. 2011;171(20):1821-1828.

11. Kuehn C, Graf K, Heuer W, et al. Economic implications of infections of implantable cardiac devices in a single institution // Eur J Cardiothorac Surg. 2010;37((4)):875-879.

12. Kirkfeldt, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark // Eur Heart J. 2014 May 7; 35(18): 1186-1194.

13. Reddy VY, Knops RE, Sperzel J et al. Permanent lead-less cardiac pacing: results of the LEADLESS trial // Circulation 2014;29:1466-1471.

14. Ritter P, Duray GZ, Steinwender C et al. Early performance of a miniaturized leadless cardiac pacemaker: The Micra Transcatheter Pacing Study // Eur Heart J 2015; 36:2510-9.

15. Coates S, Thwaites B. The Strength-Duration Curve and Its Importance in Pacing Efficiency: A Study of 325 Pacing Leads in 229 Patients // Pacing Clin Electrophysiol 2000;23:1273-1277.